PMDA inspection

Alnylam Pharmaceuticals, Inc.

PMDA inspection 5130508039570 · USA · Suitable

Key facts

Control number 5130508039570
Manufacturing site Alnylam Pharmaceuticals, Inc.
Location 665 Concord Avenue, Cambridge, MA 02138, USA
Country USA
Product type Pharmaceuticals
Application type Regular
Inspection method On-Site
Inspection month Aug 1, 2024
Result Suitable
Result notified Sep 26, 2024
PMDA registration AG30400602

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)